Availability & Price Landscape

Basic Toloxin Information

• INN (International Nonproprietary Name): Digoxin
• Brand Names Available In Canada (English): not specified
• ATC Code: C01AA05 (Cardiac Therapy → Cardiac Glycosides → Digitalis Glycosides → Digoxin)
• Forms & Dosages: Tablets 0.0625 mg, 0.125 mg, 0.25 mg; oral solution 0.05 mg/mL; injection 0.25 mg/mL (2 mL ampoule)
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription-only (Rx)

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Where patients usually look first is at the big retail chains across provinces.

Shoppers Drug Mart, Rexall and London Drugs commonly stock digoxin tablets in the usual strengths of 0.125 mg and 0.25 mg for prescription fulfilment.

Smaller or less-common strengths and oral solution may be ordered in from wholesalers and can take 24–72 hours to arrive at the store.

Pharmacists will verify prescriptions and may supply generic digoxin or brand equivalents where available.

Expect a pharmacist review when changing strengths or when interacting medications are present; ID may be requested for patient profile confirmation.

Common contact points and in-store availability:

• Shoppers Drug Mart — typical shelf stock: 0.125 mg, 0.25 mg; store ordering available.
• Rexall — typical shelf stock: 0.125 mg, 0.25 mg; regional warehousing affects supply.
• London Drugs — Western Canada focus; common strengths on shelf, oral solution less common.
• Regional Banners (Jean Coutu in Quebec) — brand availability and processes vary by province.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Online pharmacies in Canada, both chain-run and independent, commonly dispense digoxin with an e-prescription or a transferred prescription from your doctor.

Dispensing and reimbursement depend on provincial telepharmacy rules and the adjudication of provincial drug plans such as the Ontario Drug Benefit (ODB), BC PharmaCare and RAMQ in Quebec.

Cross-border ordering from U.S. suppliers does occur, but such purchases carry safety and regulatory risks if the product lacks a Canadian DIN.

Health Canada DIN verification is essential to confirm that a product meets Canadian licensing and labelling standards.

Price Ranges By Package Size (With Provincial Differences)

Retail pricing varies by brand versus generic status and by pack size, with larger bottles generally offering a lower per-tablet cost.

Provincial formularies and public drug plans can reduce out-of-pocket costs for eligible patients, but coverage depends on the plan and medical documentation of indication.

Typical price patterns:

• Small packs (30 tablets): higher per-tablet price compared with larger bottles.
• Larger bottles (90–100 tablets): lower per-tablet price; often preferred for chronic therapy.
• Oral solution and less-common tablet strengths usually cost more and are less frequently stocked.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Patients in Canada often compare notes on platforms such as Reddit (r/AskDocsCanada and other subreddits), HealthBoards and condition-specific forums.

Common discussion points include dosing confusion, monitoring schedules, visual symptoms, and difficulty obtaining specific strengths at certain pharmacies.

Urban chain pharmacies are frequently praised for fast refills, while smaller community pharmacies and hospital outpatient clinics receive mixed comments depending on local stock and counselling time.

"I was told to get bloodwork two weeks after starting—my clinic booked it for me."

"My pharmacy had 0.125 mg on the shelf but had to order 0.0625 mg for paediatric dosing."

Overall sentiment skews cautiously positive when monitoring and counselling are consistent, and negative when lab access or drug interactions are not clearly explained.

Reported Benefits And Challenges From Canadian Patients

Patients often report better rate control in atrial fibrillation and symptomatic improvement in some heart-failure cases when doses are optimised.

Many appreciate the affordable cost of generic digoxin compared with newer agents.

Common challenges include the narrow therapeutic window and the need for regular bloodwork to check serum digoxin concentration, electrolytes and renal function.

Interaction anxiety is frequent, especially with potassium-affecting diuretics and with drugs like amiodarone.

Quebec patients frequently mention RAMQ paperwork and occasional brand availability issues at Jean Coutu branches.

Ontario posts often refer to ODB coverage for eligible seniors and recipients.

Pros:

• Effective rate control in selected AF patients.
• Low-cost generic options.
• Oral and injectable forms available for different care settings.

Cons:

• Frequent monitoring required.
• Narrow therapeutic range and interaction risks.
• Occasional uncertainty about imports and lack of DIN.

Product Overview & Brand Variants

INN And Brand Names Used In Canada

The international nonproprietary name for Toloxin is digoxin, which is the active compound listed in Health Canada-style product monographs.

Globally recognised brand names include Lanoxin, and generics are produced by manufacturers such as Amneal and Mylan in other markets.

The raw product data lists Lanoxin and multiple generic labels in the United States and Europe, but specific brand listings for Canada are not specified in the available raw data.

Always confirm the exact branding and formulation with your pharmacist and check the packaging DIN before use.

Legal Classification Under Health Canada

Digoxin/Toloxin is classified as a prescription-only cardiac glycoside under international and national regulatory frameworks.

Health Canada issues market authorizations and links them to Drug Identification Numbers (DINs) that identify the manufacturer, strength and form.

Products commonly list tablet strengths (0.0625 mg, 0.125 mg, 0.25 mg), an oral solution (0.05 mg/mL) and injectable forms intended for hospital use (0.25 mg/mL).

Before purchase or reimbursement, verify the product DIN using the Health Canada Drug Product Database.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

Digoxin is used in Canada consistent with international indications, primarily for chronic heart failure and for rate control in atrial fibrillation.

Prescribers generally document the indication when submitting claims to provincial drug plans to support adjudication and reimbursement.

Ensure prescriptions specify formulation and strength so the pharmacist can match the prescription to the DIN-listed product during dispensing.

Off-Label Patterns In Canadian Healthcare

Off-label use can be appropriate in specific scenarios such as certain paediatric dosing regimens or symptomatic control when clinicians document a clear rationale and monitoring plan.

Canadian cardiologists and family physicians may prefer other rate-control agents like beta-blockers or amiodarone depending on comorbidities and patient tolerance.

Digoxin more commonly serves as an adjunct rather than a first-line agent for rate control in contemporary practice.

Regional formularies and hospital protocols influence how often digoxin appears on treatment plans.

• Approved: Chronic heart failure to reduce hospital admissions in selected patients; AF rate control.
• Off-label examples: Specific paediatric regimens, adjunct symptomatic control with specialist oversight.
• Prescriber considerations: renal function, drug interactions, patient age and monitoring capacity.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

Toloxin, whose active ingredient is digoxin, helps the heart by making each beat stronger and by slowing down some of the electrical signals that cause a fast heartbeat in atrial fibrillation.

When the dose is right, patients often notice less breathlessness and better activity tolerance.

Because the helpful dose is close to the dose that causes harm, regular blood tests and symptom checks are essential to stay safe.

Clinical Detail From Health Canada Resources

Digoxin is a cardiac glycoside that inhibits the Na+/K+-ATPase pump in cardiac cells.

This inhibition increases intracellular calcium, producing a positive inotropic effect (stronger contractions) and vagomimetic effects that slow atrioventricular conduction.

Clinical monitoring emphasises serum digoxin concentration, renal function and electrolytes because digoxin is cleared mainly by the kidneys and interacts with drugs that change potassium or magnesium.

• Na+/K+-ATPase: Cellular pump inhibited by digoxin.
• Inotropic: Increases the force of heart contractions.
• Vagomimetic: Mimics vagus nerve activity to slow heart rate.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

Adult maintenance dosing commonly falls between 0.125 mg and 0.25 mg once daily, individualised to weight, renal function and clinical response.

Initial dosing may be conservative in elderly patients to reduce the risk of accumulation and toxicity.

Pediatric dosing is weight-based, roughly 5–10 mcg/kg/day orally, and requires precise measurement or specialised formulations.

Steady-state monitoring and serum level checks guide ongoing dose adjustments.

Adjustments By Patient Type (With Canadian Clinical Notes)

Renal impairment requires substantial dose reduction and more frequent monitoring of serum digoxin and renal function.

Elderly patients often start at the lower end of the dosing range because renal clearance typically declines with age.

Inpatients needing acute therapy may receive parenteral digoxin according to hospital protocols using the 0.25 mg/mL ampoule.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Absolute contraindications include ventricular fibrillation, known hypersensitivity to digitalis glycosides, acute myocarditis, and severe AV block or sick sinus syndrome unless paced.

Common adverse effects include nausea, vomiting, diarrhoea, dizziness, headache and visual disturbances such as blurred or yellow vision.

Patients must report new or worsening arrhythmias, severe dizziness or marked visual changes promptly.

Rare But Serious (With Canadian Pharmacovigilance Data)

Severe toxicity can cause life-threatening arrhythmias, pronounced bradycardia, confusion and severe visual disturbances.

Electrolyte imbalances like hypokalaemia and hypomagnesaemia increase the risk of digoxin toxicity.

MedEffect Canada collects adverse-event reports and healthcare professionals should counsel patients on toxicity signs and emergency steps.

• Checklist For Patient Counselling: signs of toxicity, when to seek emergency care, need for lab tests, medication interactions to avoid.
• Emergency Steps: stop medication if severe symptoms occur and seek urgent medical attention.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Pros And Cons List

Pros of digoxin include low cost, oral and injectable formulations, and utility in selected heart-failure and atrial fibrillation patients.

Cons include a narrow therapeutic window, renal clearance demanding dose adjustment, and multiple drug interactions requiring careful monitoring.

For many patients, beta-blockers or newer heart-failure agents may be preferred; prescriber and formulary guidance will determine the best choice.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

Recent literature examines digoxin's role in modern heart-failure management, safety in elderly populations and comparative effectiveness against other rate-control strategies.

Canadian administrative datasets and registries have contributed observational analyses of digoxin-associated outcomes and readmission rates.

International studies through 2022–2025 focus on optimal serum-level targets, interactions with newer heart-failure therapies and deprescribing in frail older adults.

Practical Implications For Canadian Practice

Emerging guidance supports individualised serum digoxin targets and careful deprescribing when polypharmacy and frailty increase risk.

Pharmacists in community practice increasingly support monitoring, patient education and e-prescription reconciliation to reduce adverse events.

Clinicians should balance potential benefits for symptom control and readmission reduction against toxicity risks in older patients.

Common Patient Questions In Canada

Typical Q&A (Prescription, Monitoring, Interactions)

Q: Do I need a prescription for Toloxin?

A: Yes—digoxin/Toloxin is prescription-only; pharmacies will check the DIN and a valid prescription before dispensing.

Q: How often do I need blood tests?

A: Initial levels are measured after steady state, then periodic serum digoxin, renal function and electrolytes are checked; frequency is tailored to changes in medication, renal function or symptoms.

Q: Can I take it with my diuretic?

A: Many diuretics affect potassium and magnesium and can increase digoxin toxicity risk; your pharmacist or physician should assess and monitor.

Q: Can I buy from U.S. suppliers?

A: Cross-border purchases occur but risk unverified products lacking a Canadian DIN; discuss with your pharmacist before importing medicines.

Quick Reference Checklist For Patients:

• Keep a medication card with drug name, dose, DIN and emergency contact.
• Baseline ECG, renal function and electrolytes before or shortly after starting.
• Report nausea, visual changes, dizziness or palpitations immediately.

Regulatory Status

Health Canada Approval Process

Health Canada assesses the safety, efficacy and manufacturing quality of digoxin-containing products and issues market authorizations tracked by DINs.

Oral community formulations and hospital injectable forms are regulated with appropriate labelling and monographs.

Check the Drug Product Database to confirm a product's authorization and DIN before dispensing or claiming under a provincial drug plan.

DIN Number Relevance

The DIN links a product to its manufacturer, strength, formulation and packaging and is essential for dispensing, reimbursement and recall tracing.

Patients and pharmacists should verify the DIN to ensure the supplied product matches the prescriber’s order and provincial plan requirements.

• DIN: Drug Identification Number for prescription and licensed products.
• NPN: Natural Product Number, for non-prescription natural health products (not applicable to digoxin).

Visual Recommendations

Infographic Ideas For Canadian Context

Recommended visuals include a simple infographic showing how digoxin works, a clear monitoring timeline (start, steady-state, periodic lab checks) and a "When To Seek Urgent Care" warning box tailored to Canadian emergency services.

Provincial icons (ON, BC, QC) help communicate differences in coverage and dispensing rules.

Product Page Visual Blocks And Accessibility

Use a clear labelled product image that prominently shows the strength and DIN position, and include quick-tabbed lists for indications, dosing and side effects.

Provide alt-text, plain-language captions and bilingual prompts for Quebec where appropriate, and offer a downloadable PDF handout for patients.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

In-store purchases allow direct pharmacist counselling and immediate pickup; bring your provincial drug card for claims with ODB, PharmaCare or RAMQ.

Online purchasers should use Canadian-licensed pharmacies, confirm the product DIN on the listing and ensure e-prescription handling complies with provincial telepharmacy regulations.

In our online pharmacy, toloxin is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Avoid unverified cross-border sellers that do not list a Canadian DIN.

Proper Storage With Canadian Climate Considerations

Store tablets at room temperature, approximately 20–25°C (68–77°F), away from humidity and direct heat.

Do not store in bathrooms where humidity is high, and protect medications from freezing in cold Canadian winters when transporting in uninsulated conditions.

Keep in original packaging with the DIN visible and out of reach of children.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

Counselling should be clear and practical: clarify the reason for digoxin, the exact dose and timing, when to have labs and which drugs increase risk.

Ask patients to carry a medication card with Toloxin/digoxin name, dose and DIN, and encourage them to bring all medications to every appointment for reconciliation.

Checklist For Safe Long-Term Use

Safe-use checklist:

• Verify DIN and packaging at every refill.
• Obtain baseline ECG, renal function and electrolytes.
• Set a target serum digoxin level with the prescriber and schedule monitoring.
• Review all medications whenever new drugs are added or removed.
• Have an action plan for missed doses and potential overdose.
• Follow provincial refill and prior authorisation requirements when applicable.

Delivery Across Canada (English)